Search results for "ascites"

showing 10 items of 94 documents

Verapamil Inhibits the Respiration Rate of Cancer Cells

1986

Calcium antagonists have successfully been used in the treatment of hypertension, cardiac arrhythmias and coronary heart disease. Recent evidence has suggested that such agents may also play a role in the treatment of malignant tumors. Verapamil, a calcium entry blocker, has been reported to enhance the cytotoxicity of several anticancer drugs under in vitro- and in vivo-conditions [1–10]. The effects observed could be explained by an enhanced drug accumulation due to a Verapamil-induced inhibition of the drug efflux from the cancer cells.

Drugbusiness.industrymedia_common.quotation_subjectchemistry.chemical_elementPharmacologyCalciumIn vitroEhrlich ascites carcinomachemistryCancer cellcardiovascular systemmedicineVerapamilEffluxCytotoxicitybusinessmedia_commonmedicine.drug
researchProduct

Fetal presentation of Morquio disease type A.

1992

A fetus with mucopolysaccharidosis type IV A (Morquio type A) is described. The family had one affected child exhibiting symptoms of classical Morquio A disease, and late in the subsequent pregnancy prenatal diagnosis was requested. At 23 weeks' gestation, moderate ascites was detected by detailed ultrasound scan and keratan sulphate was found in the amniotic fluid. The pregnancy was terminated by prostaglandin induction and the diagnosis of mucopolysaccharidosis type IV A was confirmed by demonstration of a deficiency of N-acetylgalactosamine-6-sulphate (GalNac-6-S) sulphatase in cultured amniotic cells and in post-mortem fibroblast cultures. The activities of beta-galactosidase and arylsu…

ElectrophoresisMalemedicine.medical_specialtyAmniotic fluidPlacentaMucopolysaccharidosis type IVNeuraminidasePrenatal diagnosisConsanguinityPregnancyHydrops fetalisInternal medicineLysosomal storage diseaseMedicineHumansChildGenetics (clinical)GlycosaminoglycansUltrasonographyFetusPregnancybusiness.industryObstetrics and GynecologyAscitesMucopolysaccharidosis IVmedicine.diseaseAmniotic Fluidbeta-GalactosidaseEndocrinologyKeratan SulfatePregnancy Trimester SecondMucopolysaccharidosis IVAmniocentesisFemaleSulfatasesbusinessPrenatal diagnosis
researchProduct

Spontaneous rupture of umbilical hernia in end stage liver disease patient: injection of fibrin glue as a temporary solution.

2021

Background. Umbilical hernia is a common disease, which occurs in 20% of cirrhotic patients in the presence of persistent ascites. A rare but dangerous complication of this disease in end stage liver patient is a spontaneous rupture of umbilical hernia with ascitic fluid leaking. Up to date there is no general consensus on its most appropriate treatment. Case report. A 60 years-old male patient, with Child Pugh C and Meld score of 18 end stage liver disease, came to our observation for a spontaneous minimal rupture of his long lasting 5 cm umbilical hernia with ascitic fluid leaking. A medical therapy was undertaken aiming to manage the ascites and a temporary conservative therapy, with fib…

End Stage Liver DiseaseLiver CirrhosisMaleRupture SpontaneousUmbilical herniaHernioplastyAscitesHumansFibrin Tissue AdhesiveMiddle AgedFlood syndromeHernia UmbilicalLa Clinica terapeutica
researchProduct

Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.

2007

Abstract Context: Ovarian hyperstimulation syndrome (OHSS) results from increased vascular permeability (VP) caused by ovarian hypersecretion of vascular endothelial growth factor (VEGF), which activates its receptor-2. In animals, the dopamine receptor 2 agonist cabergoline (Cb2) inactivates VEGF receptor-2 and prevents increased VP. Objective: Our objective was to test whether Cb2 reduces VP and prevents OHSS in humans. Design: We conducted a prospective, randomized, double-blind study on oocyte donors at risk of developing OHSS (>20 follicles, >12 mm developed, and >20 oocytes retrieved). Interventions: Cb2 0.5 mg/d (n = 37) or a placebo (n = 32) was administered fro…

Endocrinology Diabetes and MetabolismClinical BiochemistryOvarian hyperstimulation syndromeVascular permeabilityHematocritBiochemistrychemistry.chemical_compoundHemoglobinsEndocrinologyPregnancyAscitesImage Processing Computer-AssistedMedicineProspective Studiesmedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionObstetrics and GynecologyAscitesGeneral MedicineHemoconcentrationMagnetic Resonance ImagingVascular endothelial growth factorHematocritDopamine AgonistsFemalemedicine.symptommedicine.drugAgonistAdultmedicine.medical_specialtyCabergolinemedicine.drug_classContext (language use)Fertilization in VitroDopamine agonistOvarian Hyperstimulation SyndromeDouble-Blind MethodInternal medicineCabergolineLuteal CellsHumansErgolinesGranulosa Cellsbusiness.industryReceptors Dopamine D2Peritoneal fluidBiochemistry (medical)Ovarymedicine.diseaseEndocrinologychemistryRegional Blood FlowbusinessExtracellular SpaceThe Journal of clinical endocrinology and metabolism
researchProduct

2015

Primary intestinal lymphangiectasia (PIL) is a rare disorder, especially in adults. It causes a local disruption of chylus transport and is part of the exudative gastroenteropathies. Conservative therapy includes dietary measures or somatostatin medication. Taking the differential diagnosis of PIL into consideration is a major challenge, since patients suffering from PIL may present with diarrhoea and lymphedema or chylous ascites. This can be explained by the chronic lymphedema of the bowel leading to dilation of the vessels (intraluminal loss) and sometimes even to a rupture (peritoneal loss). Push–pull enteroscopy and capsule endoscopy are the proper interventional diagnostic tools to di…

Enteroscopymedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.diseaseGastroenterologySurgerylaw.inventionDiarrheaLymphedemaCapsule endoscopylawInternal medicineIntestinal lymphangiectasiaChylous ascitesmedicineSurgeryDifferential diagnosismedicine.symptomLaparoscopybusinessJournal of Surgical Case Reports
researchProduct

Hyperlactacidaemia in isolated hyperthermic perfusion of tumour bearing rat limbs: a study of feasibility using a novel infusion solution.

1999

In a methodological study the applicability of hyperlactacidaemia in isolated hyperthermic perfusion of tumour-bearing rat limbs was investigated.In 50 Sprague Dawley rats, DS-sarcoma growth was initiated on the right food dorsum by subcutaneous injection of 0.5 ml ascites cells. In the anaesthetized animals isolated limb perfusion was performed under steady state conditions for 60min using a miniature equipment. Thereafter tumour volume was measured daily. (a) Investigation of feasability: 40 rats were allocated to four groups. Group I: Normothermic perfusion at 38 degrees C, n = 10; Group II: Hyperthermic perfusion at 40-41 degrees C, n = 10; Group III: Normothermic perfusion at 38 degree…

HyperthermiaCancer ResearchPathologymedicine.medical_specialtyPhysiologyHyperthermic perfusionRats Sprague-DawleySubcutaneous injectionPhysiology (medical)AscitesmedicineSprague dawley ratsAnimalsImmunologic FactorsLactic AcidInfusion solutionbusiness.industryExtremitiesHyperthermia Inducedmedicine.diseaseRatsAnesthesiaChemotherapy Cancer Regional PerfusionFeasibility StudiesMethodological studyFemaleSarcoma Experimentalmedicine.symptombusinessPerfusionInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
researchProduct

In vivo targets of recombinant human tumour necrosis factor-α: blood flow, oxygen consumption and growth of isotransplanted rat tumours

1989

The impact of recombinant human tumour necrosis factor-alpha (1 microgram kg-1 to 1 mg kg-1; 6.6 x 10(6) U mg protein-1) on blood flow, oxygen consumption and growth of a moderately TNF-sensitive rat tumour (DS-carcinosarcoma) was studied. Tumour growth was stimulated at low TNF doses (1 and 10 micrograms kg-1) and significantly retarded at higher TNF dose levels (0.1 and 1 mg kg-1). Growth changes were concomitant with variations in oxygen consumption, lactate release and acidification of the metabolic micromilieu. Both single and repeated application of low TNF doses (1-10 micrograms kg-1 i.v.) increased tumour perfusion whereas single administration of high TNF dose levels (0.1-1 mg kg-1…

HyperthermiaCancer Researchmedicine.medical_specialtyNecrosismedicine.medical_treatmentBiologyOxygen ConsumptionCarcinosarcomaIn vivoInternal medicinemedicineAnimalsChemotherapyTumor Necrosis Factor-alphaCell growthAscitesRats Inbred StrainsBlood flowmedicine.diseaseRecombinant ProteinsRatsEndocrinologyOncologyRegional Blood FlowTumor necrosis factor alphamedicine.symptomPerfusionNeoplasm TransplantationResearch ArticleBritish Journal of Cancer
researchProduct

New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

2021

Traditionally, the complications of cirrhosis, namely variceal bleeding, ascites and hepatic encephalopathy, were thought to result predominantly from circulatory dysfunction and altered organ perfusion arising as a result of portal hypertension. Over the past 20 years, large, international prospective studies have indicated the importance of systemic inflammation and organ immunopathology as additional determinants of organ dysfunction in cirrhosis, which not only manifests in the liver, brain, circulation and the kidneys, but also the immune system, gut, muscles, adrenal glands, reproductive organs, heart and lungs. This review provides an overview of the traditional and emerging concepts…

Liver Cirrhosis0301 basic medicinemedicine.medical_specialtyVaricesCirrhosisSystemic inflammationImmune System Phenomena03 medical and health sciences0302 clinical medicineImmunopathologyAscitesmedicineAcute on chronic liver failureHumansDecompensationIntensive care medicineHepatic encephalopathyHepatic encephalopathyInflammationHepatologybusiness.industryResearchOrgan dysfunctionGastroenterologyAscitesAcute on chronic liver failure; Ascites; Cirrhosis; Hepatic encephalopathy; Infection; Inflammation; Varicesmedicine.disease030104 developmental biologyCirrhosisDisease ProgressionPortal hypertension030211 gastroenterology & hepatologymedicine.symptombusinessInfection
researchProduct

Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites.

2011

Several studies have shown the efficacy of hypertonic saline solution infusion in conditions in which regional organ blood flow is impaired. Our group has shown that treatment of patients with diuretic-resistant heart failure with high-dose furosemide plus hypertonic saline is effective and well tolerated, improving symptoms of congestion, reducing plasma levels of markers of neurohormonal and inflammatory activation, decreasing hospital readmission rates, and reducing long-term mortality. The same regimen was shown to be better than repeated paracentesis in patients with cirrhosis and refractory ascites, yielding better control of ascites, pleural effusions, and/or leg edema without an inc…

Liver CirrhosisCirrhosisFurosemideAscitesmedicineParacentesisHumansAdverse effectDiureticsInfusions IntravenousHepatic encephalopathyHeart FailureSaline Solution Hypertonicmedicine.diagnostic_testCardio-Renal Syndromebusiness.industryFurosemideAscitesmedicine.diseaseHypertonic salineNephrologyAnesthesiaHeart failuremedicine.symptombusinessmedicine.drugSeminars in nephrology
researchProduct

Umbilical hernioplasty in cirrhotic patients with ascites A case control study

2021

Umbilical hernia is a very frequent pathology, and plastic with prosthetic material is the most frequently used surgical procedure currently used for its repair. In patients with cirrhosis in asciic phase, this pathology is particularly frequent, with a tendency to rapidly increase in size and to become symptomatic. In the past treatment with traditional surgery in cirrhotic patients was considered problematic and was viewed with reserve, and only recently is the surgical approach recommended also in these patients. This study is aimed to evaluate the feasibility and safety of open umbilical hernia plastic with prosthetic material in cirrhotic and ascitic patients.Our case-control study was…

Liver CirrhosisMaleCase-Control StudiesAscitesHumanshernioplastyHernia UmbilicalHerniorrhaphy
researchProduct